Santoke Naal is an experienced executive in the pharmaceutical and life sciences sectors, currently serving as General Manager at IGES Institut GmbH since 2022. Previously held significant roles including Director of Commercial Strategy at the Association of the British Pharmaceutical Industry (ABPI), where key negotiations with the NHS and Department of Health were executed. As Director and Founder of Prados Embalados, Santoke led the setup of clinical trials and secured endorsement and funding essential for operations. Other notable positions include Principal Head of Market Access at IQVIA and Managing Director for UK and Ireland Oncology at Pierre Fabre Group, showcasing a track record of driving growth, securing funding, and fostering strategic relationships. Santoke's educational background includes a Diploma in Company Direction from the Institute of Directors and a Bachelor of Science degree in Biochemistry/Chemistry from the University of Leeds.